Brainstorm Net Income Applicable To Common Shares from 2010 to 2026

BCLI Stock  USD 0.54  0.04  6.86%   
Brainstorm Cell's Net Loss is decreasing with slightly volatile movements from year to year. Net Loss is estimated to finish at about -20.8 M this year. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-03-31
Previous Quarter
-5.1 M
Current Value
-5.3 M
Quarterly Volatility
2.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 226.4 K, Interest Expense of 65.8 K or Selling General Administrative of 4.4 M, as well as many indicators such as Price To Sales Ratio of 17.14, Dividend Yield of 0.0 or Days Sales Outstanding of 21.66. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
  
Build AI portfolio with Brainstorm Stock
Check out the analysis of Brainstorm Cell Correlation against competitors.
The Net Income Applicable To Common Shares trend for Brainstorm Cell Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Brainstorm Cell is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Brainstorm Cell's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Brainstorm Cell Therapeutics over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Brainstorm Cell's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brainstorm Cell's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Brainstorm Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(14,867,008)
Coefficient Of Variation(65.94)
Mean Deviation8,943,773
Median(13,948,000)
Standard Deviation9,802,929
Sample Variance96.1T
Range28.4M
R-Value(0.84)
Mean Square Error30.9T
R-Squared0.70
Significance0.000029
Slope(1,623,019)
Total Sum of Squares1537.6T

Brainstorm Net Income Applicable To Common Shares History

2026-20.8 M
2025-21.8 M
2022-24.3 M
2021-24.5 M
2020-31.8 M
2019-23.3 M
2018-13.9 M

About Brainstorm Cell Financial Statements

Investors use fundamental indicators, such as Brainstorm Cell's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Loss-21.8 M-20.8 M

Currently Active Assets on Macroaxis

When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out the analysis of Brainstorm Cell Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is there potential for Biotechnology market expansion? Will Brainstorm introduce new products? Factors like these will boost the valuation of Brainstorm Cell. Projected growth potential of Brainstorm fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.42)
Return On Assets
(4.00)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainstorm Cell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainstorm Cell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainstorm Cell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.